R. Wei

Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL

H. Li, J. Gui, X. Cao, 2011, Cancer Gene Therapy.

Cancer targeting gene-viro-therapy specific for liver cancer by α-fetoprotein-controlled oncolytic adenovirus expression of SOCS3 and IL-24.

Yan Zeng, Xin-Yuan Liu, Kang-Jian Zhang, 2011, Acta biochimica et biophysica Sinica.

Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.

Q. Qian, Xin-Yuan Liu, Xiu-mei Zhou, 2011, Human gene therapy.

Cancer Targeting Gene-Viro-Therapy and Its Promising Future: A Trend in Both Cancer Gene Therapy and Cancer Virotherapy

Wenlin Huang, Q. Qian, W. Zou, 2012 .

A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect

Q. Qian, Xin-Yuan Liu, Kang-Jian Zhang, 2012, Journal of cellular and molecular medicine.

Potent antitumor effect of interleukin-24 gene in the survivin promoter and retinoblastoma double-regulated oncolytic adenovirus.

Xin Yuan Liu, Kang-Jian Zhang, Xin Cao, 2009, Human gene therapy.

Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene

Q. Qian, X. Cao, M. Ding, 2011, Gene Therapy.